Cite

HARVARD Citation

    Lega, S. et al. (2019). Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD. Inflammatory bowel diseases. 25 (1), pp. 134-141. [Online]. 
  
Back to record